Loading…
Syncom Formulations (India) (SYNCOMF)₹20.10−4.33%Pharmaceuticals
At the end of the Jun 2026 quarter, Syncom Formulations (India)'s shareholders were: promoters 50.55%, FIIs 0.35%, public 49.10%. Promoter holding is unchanged on the quarter. FII holding is down 0.06 percentage points from 0.41% a year earlier. It had 4,22,131 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 50.55% | 50.55% | 50.55% | 50.55% | 50.55% | 50.55% | 50.55% | 50.55% | 50.55% | 50.55% | 50.55% | 50.55% |
| FIIs | 0.00% | 0.00% | 0.08% | 0.09% | 0.10% | 0.13% | 0.11% | 0.41% | 0.10% | 0.26% | 0.21% | 0.35% |
| Public | 49.45% | 49.45% | 49.37% | 49.36% | 49.35% | 49.32% | 49.34% | 49.04% | 49.35% | 49.19% | 49.24% | 49.10% |
| Number of shareholders | 2,24,261 | 2,89,994 | 3,25,774 | 3,76,545 | 4,69,261 | 4,89,540 | 4,84,549 | 4,71,085 | 4,57,383 | 4,42,298 | 4,31,707 | 4,22,131 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Kedarmal Shankarlal Bankda | Promoter | 12.38% | 0.00 |
| Vijay Shankarlal Bankda | Promoter | 10.49% | 0.00 |
| Ankit Bankda | Promoter | 5.01% | 0.00 |
| Paradise Vyapar Private Limited | Promoter | 5.01% | 0.00 |
| Asha Vijay Bankda | Promoter | 4.89% | 0.00 |
| Vimla Bankda | Promoter | 4.27% | 0.00 |
| Strand Developers Pvt Ltd | Promoter | 3.86% | 0.00 |
| Vijay Bankda Huf | Promoter | 1.27% | 0.00 |
| Payal Ankur Bankda | Promoter | 1.24% | 0.00 |
| Kedarmal Shankarlal Bankda Huf | Promoter | 1.13% | 0.00 |
| Sulabh Rahul Bankda | Promoter | 0.98% | 0.00 |
| Rahul Bankda | Promoter | 0.02% | 0.00 |
| Ankur Vijay Bankda | Promoter | 0.01% | 0.00 |
Promoters held 50.55% of Syncom Formulations (India) at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.35% (up 0.14 percentage points from 0.21% a quarter earlier) and domestic institutions (DIIs) held no reported stake.
Syncom Formulations (India) had 4,22,131 shareholders at the end of the Jun 2026 quarter, against 4,71,085 a year earlier.